Sponsor

Beijing University of Chinese Medicine

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Beijing University of Chinese Medicine appears in 13 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials13
Recruiting shown0
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

13 shown
Fuyang Jiedu Granules Plus Antiretroviral Therapy for HIV Immune Non-Responders With Spleen-Kidney Yang DeficiencyNCT07698548 · lead sponsor · 2026-08-01
NOT_YET_RECRUITING
Qiling Yiqi Tablets Plus Antiretroviral Therapy for HIV Immune Non-responders With Lung-Spleen Qi DeficiencyNCT07698574 · lead sponsor · 2026-08-01
NOT_YET_RECRUITING
Electroacupuncture for Chemotherapy-Related Cognitive ImpairmentNCT05941598 · lead sponsor · 2023-08-01
UNKNOWN
Modified Zhiwang Decoction Combined With Methotrexate in the Treatment of Early Rheumatoid ArthritisNCT05508815 · lead sponsor · 2023-02-09
UNKNOWN
IPS Differentiated Cardiomyocytes Vein Transplantation for Chronic Heart FailureNCT03759405 · lead sponsor · 2022-12-31
UNKNOWN
Tangningtongluo Tablet for People With PrediabetesNCT05126251 · lead sponsor · 2021-12-13
UNKNOWN
Evaluating the Safety and Efficacy of Qishen Granules Among Patients With Chronic Heart FailureNCT03027375 · lead sponsor · 2017-03-31
UNKNOWN
Traditional Chinese Medicine for Treatment of Chronic Heart FailureNCT01939236 · lead sponsor · 2010-05-01
COMPLETED
Observation Study on the Efficacy of Yiqi Gubiao Pill in the Treatment of Chronic Obstructive Pulmonary Disease Secondary to Active Pulmonary TuberculosisNCT06676800 · collaborator · 2024-11-30
NOT_YET_RECRUITING
The Efficacy and Safety Assessment of Huafu Shengji Ointment in Patients With Diabetic Foot of Qi Deficiency and Blood Stasis SyndromeNCT06487117 · collaborator · 2024-09-01
UNKNOWN
Acupuncture in the Regulation of Dai Meridian for Polycystic Ovarian Syndrome Patients With Abdominal ObesityNCT02785965 · collaborator · 2016-07-01
UNKNOWN
Acupuncture in the Regulation of Dai Meridian for the Metabolism of Visceral Adipose Tissue in Abdominal Obese PatientsNCT02427347 · collaborator · 2014-06-01
COMPLETED
Trial of Herb Yuyang Ointment to Diabetic Foot UlcerNCT00839865 · collaborator · 2008-11-01
UNKNOWN

Drugs studied in this sponsor's trials

2 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Beijing University of Chinese Medicine as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.
methotrexate1
placebo1

Sponsor roles

lead sponsor8
collaborator5
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.